Université de Strasbourg

Sylviane Muller

Chair of Therapeutic Immunology

Sylviane MullerSylviane Muller is a research director at CNRS. Since 2001 she heads the CNRS Laboratory of Therapeutic Immunology and Chemistry at the Institute of Molecular and Cellular Biology in Strasbourg (IBMC). She earned her doctorate in Sciences at the University of Strasbourg and was a postdoctoral researcher in Freiburg (Germany) at the Max-Planck Institute for Immunobiology. Her field of expertise covers autoimmunity, immuno-peptides and synthetic vaccines. Her team studies the molecular and cellular bases of the normal immune response and dysfunction, to find novel therapeutic approaches to treat autoimmune, tumoral and infectious diseases. With her team, she has discovered and patented a molecule capable of correcting the immune system in an autoimmune disease, systemic lupus erythematosus, for which no specific treatment currently exists. She was awarded the Silver Medal of CNRS (2010).

Professor Muller holds 24 patents and has published more than 330 publications and review articles/chapters. She was one of the founders of the companies Neosystem (today Polypeptide France) and ImmuPharma. With many patents and the creation of two companies, society benefits from tangible benefits of her lab’s research.

On 10 June 2015, Sylviane Muller received the CNRS Innovation Medal 2015, a prestigious award recognizing individuals whose outstanding research leads to breakthrough innovations in terms of technological, medical and societal applications.

In the USIAS Board, Professor Muller holds the position of Secretary of the Board, supporting the Director in representation and in strategic decision-making.

Investissements d'Avenir